Literature DB >> 15292358

Expression of SHOX in human fetal and childhood growth plate.

C J F Munns1, H R Haase, L M Crowther, M T Hayes, R Blaschke, G Rappold, I A Glass, J A Batch.   

Abstract

Abnormalities in the growth plate may lead to short stature and skeletal deformity including Leri Weil syndrome, which has been shown to result from deletions or mutations in the SHOX gene, a homeobox gene located at the pseudoautosomal region of the X and Y chromosome. We studied the expression of SHOX protein, by immunohistochemistry, in human fetal and childhood growth plates and mRNA by in situ hybridization in childhood normal and Leri Weil growth plate. SHOX protein was found in reserve, proliferative, and hypertrophic zones of fetal growth plate from 12 wk to term and childhood control and Leri Weil growth plates. The pattern of immunostaining in the proliferative zone of childhood growth plate was patchy, with more intense uniform immunostaining in the hypertrophic zone. In situ hybridization studies of childhood growth plate demonstrated SHOX mRNA expression throughout the growth plate. No difference in the pattern of SHOX protein or mRNA expression was seen between the control and Leri Weil growth plate. These findings suggest that SHOX plays a role in chondrocyte function in the growth plate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292358     DOI: 10.1210/jc.2003-032230

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  The role of Shox2 in SAN development and function.

Authors:  Hongbing Liu; Ramón A Espinoza-Lewis; Chaohui Chen; Xuefeng Hu; Yanding Zhang; Yiping Chen
Journal:  Pediatr Cardiol       Date:  2012-02-04       Impact factor: 1.655

2.  A mouse model for human short-stature syndromes identifies Shox2 as an upstream regulator of Runx2 during long-bone development.

Authors:  John Cobb; Andrée Dierich; Yolande Huss-Garcia; Denis Duboule
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

3.  Ontogenetic changes of craniofacial complex in Turner syndrome patients treated with growth hormone.

Authors:  Jovana Juloski; Branislav Glisic; Ivana Scepan; Jelena Milasin; Katarina Mitrovic; Marko Babic
Journal:  Clin Oral Investig       Date:  2012-09-23       Impact factor: 3.573

Review 4.  Growth hormone treatment in non-growth hormone-deficient children.

Authors:  Sandro Loche; Luisanna Carta; Anastasia Ibba; Chiara Guzzetti
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-03-31

5.  Detection of SHOX gene aberrations in routine diagnostic practice and evaluation of phenotype scoring form effectiveness.

Authors:  Katerina Hirschfeldova; Martina Florianova; Vera Kebrdlova; Marketa Urbanova; Jitka Stekrova
Journal:  J Hum Genet       Date:  2016-10-06       Impact factor: 3.172

6.  Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency.

Authors:  Gudrun Rappold; Werner F Blum; Elena P Shavrikova; Brenda J Crowe; Ralph Roeth; Charmian A Quigley; Judith L Ross; Beate Niesler
Journal:  J Med Genet       Date:  2006-12-20       Impact factor: 6.318

7.  Prevalence of SHOX haploinsufficiency among short statured children.

Authors:  Maja Rou Marstrand-Joergensen; Rikke Beck Jensen; Lise Aksglaede; Morten Duno; Anders Juul
Journal:  Pediatr Res       Date:  2016-11-04       Impact factor: 3.756

8.  A new look at XXYY syndrome: medical and psychological features.

Authors:  Nicole Tartaglia; Shanlee Davis; Alison Hench; Sheela Nimishakavi; Renee Beauregard; Ann Reynolds; Laura Fenton; Lindsey Albrecht; Judith Ross; Jeannie Visootsak; Robin Hansen; Randi Hagerman
Journal:  Am J Med Genet A       Date:  2008-06-15       Impact factor: 2.802

9.  Shox2-deficiency leads to dysplasia and ankylosis of the temporomandibular joint in mice.

Authors:  Shuping Gu; Na Wei; Ling Yu; Jian Fei; YiPing Chen
Journal:  Mech Dev       Date:  2008-04-22       Impact factor: 1.882

10.  Recombinant human growth hormone in the treatment of Turner syndrome.

Authors:  Bessie E Spiliotis
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.